Remove Access Remove Collective Remove Environment Remove Medicine
article thumbnail

Australia Cannabis Q&A

Canna Law Blog

Importation, cultivation, production, and other activities conducted for medicinal and scientific purposes are lawful under federal Australian law when the necessary licenses and permits have been obtained. This Q&A focuses primarily on medicinal cannabis (containing higher THC). Australia Cannabis Q&A A.

article thumbnail

Halo Collective Announces Reorganization of International Assets to Create Akanda, a Leading African Medical Cannabis Company

Cannabis Law Report

2021 /CNW/ – Halo Collective Inc. (“Halo”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated multinational cannabis company, today announced that its board of directors has unanimously approved the reorganization (the “International Reorganization”) of its non-U.S. TORONTO , June 22,?2021

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

All Cannabis Use Is Political

The Cannigma

There are still medical cannabis patients going to jail and losing their homes, custody of their children, and their jobs, regardless of the market from which they purchased their medicine. So while a cannabis business can join their local chamber of commerce, a patient in hospice can be denied access to medical cannabis.

Policy 80
article thumbnail

Global Regulatory Specialist – Melbourne – Medicinal Cannabis i-Pharm Consulting Australia Pty Ltd

Cannabis Law Report

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

article thumbnail

Australia: Global Regulatory Specialist – Melbourne – Medicinal Cannabis i-Pharm Consulting Melbourne VIC

Cannabis Law Report

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

article thumbnail

Not-very-NICE: UK Cannabis Policy and Harm to Patients

CannaTech

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

article thumbnail

RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands

Cannabis Law Report

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 in real terms to £4.97 to reach 3.2

Programs 100